Clinical Trial Update: A Study of STAR-0215 in Participants With Hereditary Angioedema [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating STAR-0215 in participants with hereditary angioedema has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• STAR-0215

Snippet

Sponsor: Astria Therapeutics, Inc. | Conditions: Hereditary Angioedema | Phase 1, Phase 2 | Status: COMPLETED